Taro Shibuki, Riu Yamashita, Tadayoshi Hashimoto, Takao Fujisawa, Mitsuho Imai, Junichiro Yuda, Takeshi Kuwata, Toshihiro Misumi, Yoshiaki Nakamura, Hideaki Bando, Kaname Kojima, Sayuri Tokioka, Ippei Chiba, Naoki Nakaya, Atsushi Hozawa, Seizo Koshiba, Nobuo Fuse, Sakae Saito, Ritsuko Shimizu, Woong-Yang Park, Kengo Kinoshita, Takayuki Yoshino. “Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI)” International Journal of Clinical Oncology, vol. 31, no. 5, 2026, pp. 843-850. doi:10.1007/s10147-026-03001-6